Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 7, 2023
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
Sun, August 6, 2023
[ Sun, Aug 06th 2023
] - WOPRAI
[ Sun, Aug 06th 2023
] - WOPRAI
Fri, August 4, 2023
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
[ Fri, Aug 04th 2023
] - WOPRAI
Conor McNamara Maintained (BIO) at Buy with Increased Target to $524 on, Aug 4th, 2023
Conor McNamara of RBC Capital, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Buy with Increased Target from $522 to $524 on, Aug 4th, 2023.
Conor has made no other calls on BIO in the last 4 months.
There is 1 other peer that has a rating on BIO. Out of the 1 peers that are also analyzing BIO, 0 agree with Conor's Rating of Hold.
This is the rating of the analyst that currently disagrees with Conor
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $525 on, Monday, May 8th, 2023
